WO2000046369A3 - Polynucleotides related to pancreatic disease - Google Patents
Polynucleotides related to pancreatic disease Download PDFInfo
- Publication number
- WO2000046369A3 WO2000046369A3 PCT/US2000/002913 US0002913W WO0046369A3 WO 2000046369 A3 WO2000046369 A3 WO 2000046369A3 US 0002913 W US0002913 W US 0002913W WO 0046369 A3 WO0046369 A3 WO 0046369A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pancreatic
- differentially expressed
- pancreatic disease
- methods
- polynucleotides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU29811/00A AU2981100A (en) | 1999-02-02 | 2000-02-02 | Polynucleotides related to pancreatic disease |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11830299P | 1999-02-02 | 1999-02-02 | |
US60/118,302 | 1999-02-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000046369A2 WO2000046369A2 (en) | 2000-08-10 |
WO2000046369A3 true WO2000046369A3 (en) | 2001-11-15 |
Family
ID=22377764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/002913 WO2000046369A2 (en) | 1999-02-02 | 2000-02-02 | Polynucleotides related to pancreatic disease |
Country Status (3)
Country | Link |
---|---|
US (2) | US6429302B1 (en) |
AU (1) | AU2981100A (en) |
WO (1) | WO2000046369A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6597996B1 (en) | 1999-04-23 | 2003-07-22 | Massachusetts Institute Of Technology | Method for indentifying or characterizing properties of polymeric units |
GB9914890D0 (en) * | 1999-06-25 | 1999-08-25 | Univ Buckingham | Methods and compositions relating to pancreatic islet and -cell dysfunction |
US20030068655A1 (en) * | 2001-09-12 | 2003-04-10 | Protiveris, Inc. | Microcantilever apparatus and methods for detection of enzymes |
EP1590648A4 (en) * | 2002-05-20 | 2007-04-18 | Massachusetts Inst Technology | Novel method for sequence determination using nmr |
US20060094007A1 (en) * | 2002-05-22 | 2006-05-04 | Fujisawa Pharmaceutical Co., Ltd | Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc |
US20050260639A1 (en) * | 2002-09-30 | 2005-11-24 | Oncotherapy Science, Inc. | Method for diagnosing pancreatic cancer |
US7601826B2 (en) * | 2002-09-30 | 2009-10-13 | Oncotherapy Science, Inc. | Genes and polypeptides relating to human pancreatic cancers |
AU2003900747A0 (en) * | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
GB0329997D0 (en) * | 2003-12-24 | 2004-01-28 | Cancer Rec Tech Ltd | Methods for detecting neoplasia and markers thereof |
DE102004042822A1 (en) * | 2004-08-31 | 2006-03-16 | Technische Universität Dresden | Compounds and methods of treatment, diagnosis and prognosis in pancreatic diseases |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0376746A2 (en) * | 1988-12-29 | 1990-07-04 | The Wistar Institute | Gene family of tumor-associated antigens |
WO1998053319A2 (en) * | 1997-05-21 | 1998-11-26 | The Johns Hopkins University | Gene expression profiles in normal and cancer cells |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5459037A (en) | 1993-11-12 | 1995-10-17 | The Scripps Research Institute | Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5776683A (en) | 1996-07-11 | 1998-07-07 | California Pacific Medical Center | Methods for identifying genes amplified in cancer cells |
-
2000
- 2000-01-25 US US09/490,818 patent/US6429302B1/en not_active Expired - Fee Related
- 2000-02-02 WO PCT/US2000/002913 patent/WO2000046369A2/en active Search and Examination
- 2000-02-02 AU AU29811/00A patent/AU2981100A/en not_active Abandoned
-
2002
- 2002-06-06 US US10/165,835 patent/US20020187507A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0376746A2 (en) * | 1988-12-29 | 1990-07-04 | The Wistar Institute | Gene family of tumor-associated antigens |
WO1998053319A2 (en) * | 1997-05-21 | 1998-11-26 | The Johns Hopkins University | Gene expression profiles in normal and cancer cells |
Non-Patent Citations (3)
Title |
---|
GRESS T M ET AL: "A pancreatic cancer-specific expression profile", ONCOGENE,GB,BASINGSTOKE, HANTS, vol. 13, 1 January 1996 (1996-01-01), pages 1819 - 1830, XP002089888, ISSN: 0950-9232 * |
HILLIER ET AL.: "Generation and analysis of 280,000 human expressed sequence tags", EMBL DATABASE ACC. NO: AA065079, 26 September 1996 (1996-09-26), XP002140352 * |
PAULEY: "The sequence of H. sapiens BAC clone RG083M05", EMBL DATABASE ACC. NO: AC000064, 17 November 1996 (1996-11-17), XP002140351 * |
Also Published As
Publication number | Publication date |
---|---|
AU2981100A (en) | 2000-08-25 |
WO2000046369A2 (en) | 2000-08-10 |
US6429302B1 (en) | 2002-08-06 |
US20020187507A1 (en) | 2002-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000046369A3 (en) | Polynucleotides related to pancreatic disease | |
WO2001002568A3 (en) | Human genes and gene expression products | |
WO1999035170A8 (en) | Compositions and methods for the treatment of tumor | |
WO2004031411A3 (en) | Genes and polypeptides relating to human pancreatic cancers | |
WO2003000707A3 (en) | Antisense modulation of superoxide dismutase 1, soluble expression | |
WO2000031235A3 (en) | Nucleotide and protein sequences of nogo genes and methods based thereon | |
WO2002046465A3 (en) | Method for identification of genes involved in specific diseases | |
WO2004013310A3 (en) | Methods of down regulating target gene expression in vivo by introduction of interfering rna | |
WO2003032813A3 (en) | Methods for the treatment of carcinoma | |
CA2317306A1 (en) | Soy containing breakfast cereal and process for producing | |
WO1997003192A3 (en) | Chromosome 1 gene and gene products related to alzheimer's disease | |
EP1953243A8 (en) | Polynucleotides related to colon cancer | |
WO2003076631A3 (en) | Genetic products differentially expressed in tumors and use thereof | |
WO2003062826A3 (en) | Materials and methods for examining and treating nasopharyngeal carcinoma | |
WO2004075835A3 (en) | Methods for the treatment of renal cell carcinoma | |
WO2002012440A3 (en) | Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles | |
WO2000015666A3 (en) | Compositions and methods for the treatment of tumors | |
WO2003044161A3 (en) | Gene amplification and overexpression in cancer | |
WO2000008134A3 (en) | HUMAN HtrA SERINE PROTEASE | |
EP1185696A4 (en) | Antisense oligonucleotide modulation of human protein kinase c-delta expression | |
WO2004112575A3 (en) | Gene amplification and overexpression in cancer | |
WO2000058464A3 (en) | Rab genes and their uses | |
WO2004011615A3 (en) | USES OF CIRCADIAN GENE mPER2 | |
WO2001064870A3 (en) | Mutated cyclin g1 protein | |
WO2006105343A3 (en) | Dkkl-i splice product modulators for cancer diagnosis and therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |